As of Mar 22
| +0.41 / +3.90%|
The 7 analysts offering 12-month price forecasts for ChemoCentryx Inc have a median target of 20.00, with a high estimate of 23.00 and a low estimate of 12.50. The median estimate represents a +83.32% increase from the last price of 10.91.
The current consensus among 8 polled investment analysts is to Buy stock in ChemoCentryx Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.